Surgical Biologics will operate as a wholly owned subsidiary of MiMedx Group. The company’s product portfolio includes the Purion process that follows strict guidelines for allograft processing.
MiMedx projects that 2011 company revenues from the acquisition will be in the range of $7 million.
Read the MiMedx news release on the acquisition.
Read other coverage on orthopedic and spine device acquisitions:
– DJO Acquires Elastic Therapy
– Zimmer Finalizes Acquisition of Beijing Montagne Medical Device Co.
– Hanger Orthopedic Group Completes Acquisition of Accelerated Care Plus
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
